» Articles » PMID: 1533341

CD23 and B Cell Activation

Overview
Date 1992 Feb 1
PMID 1533341
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies.

Makgoeng S, Bolanos R, Jeon C, Weiss R, Arah O, Breen E JNCI Cancer Spectr. 2019; 2(4):pky082.

PMID: 30873511 PMC: 6400235. DOI: 10.1093/jncics/pky082.


Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.

Purdue M, Lan Q, Kemp T, Hildesheim A, Weinstein S, Hofmann J Leukemia. 2015; 29(6):1429-31.

PMID: 25567136 PMC: 5432037. DOI: 10.1038/leu.2015.2.


Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection.

Rujeni N, Nausch N, Midzi N, Gwisai R, Mduluza T, Taylor D Int Arch Allergy Immunol. 2013; 161(4):333-41.

PMID: 23689700 PMC: 3795451. DOI: 10.1159/000346545.


Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.

De Roos A, Mirick D, Edlefsen K, LaCroix A, Kopecky K, Madeleine M Cancer Res. 2012; 72(18):4733-43.

PMID: 22846913 PMC: 3445724. DOI: 10.1158/0008-5472.CAN-12-1639.


B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Breen E, Hussain S, Magpantay L, Jacobson L, Detels R, Rabkin C Cancer Epidemiol Biomarkers Prev. 2011; 20(7):1303-14.

PMID: 21527584 PMC: 3132317. DOI: 10.1158/1055-9965.EPI-11-0037.